Amneal Adds Xolair Rival To Biosimilars Pipeline

Kashiv Biosciences-Developed Omalizumab Becomes Eighth Product In Amneal’s Roster

 
• By David Wallace
Red pipes on white background
Amneal is adding to its biosimilars pipeline • Source: Shutterstock

More from Biosimilars

More from Products